Ownership

Nick Pizzie

Insider Reports History

Entity: Individual
Location: 25 Broadway, 9 Th Floor, New York, NY
Signature: /s/ Nick Pizzie
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nick Pizzie:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Axsome Therapeutics, Inc.	Chief Financial Officer	Common Stock	42.2K	$5.53M	$131.07	Feb 14, 2025	Direct
Axsome Therapeutics, Inc.	Chief Financial Officer	Performance Stock Units	9.42K	$1.24M	$131.07	Feb 24, 2025	Direct
Axsome Therapeutics, Inc.	Chief Financial Officer	Restricted Stock Units	9.42K	$1.24M	$131.07	Feb 21, 2025	Direct
Axsome Therapeutics, Inc.	Chief Financial Officer	Common Stock	488	$64K	$131.07	Feb 13, 2025	Indirect
Axsome Therapeutics, Inc.	Chief Financial Officer	Stock Option (Right to Buy)	0	$0	$3.50	Feb 14, 2025	Direct
Axsome Therapeutics, Inc.	Chief Financial Officer	Employee Stock Option (Right to Buy)	9.52K			Feb 21, 2025	Direct

Showing 1 to 6 of 6 entries

Insider Reports Filed by Nick Pizzie

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
AXSM	Axsome Therapeutics, Inc.	Feb 21, 2025	3	$0	4	Feb 25, 2025	Chief Financial Officer
AXSM	Axsome Therapeutics, Inc.	Feb 13, 2025	6	-$1.95M	4	Feb 14, 2025	Chief Financial Officer
AXSM	Axsome Therapeutics, Inc.	Feb 27, 2024	2	$0	4	Feb 29, 2024	CHIEF FINANCIAL OFFICER
AXSM	Axsome Therapeutics, Inc.	Mar 2, 2023	2	$0	4	Mar 6, 2023	CHIEF FINANCIAL OFFICER
AXSM	Axsome Therapeutics, Inc.	Mar 4, 2022	2	$0	4	Mar 8, 2022	CHIEF FINANCIAL OFFICER
AXSM	Axsome Therapeutics, Inc.	Nov 18, 2021	4	$33.7K	4	Nov 22, 2021	CHIEF FINANCIAL OFFICER
AXSM	Axsome Therapeutics, Inc.	Nov 12, 2021	1	$0	4	Nov 15, 2021	CHIEF FINANCIAL OFFICER